Andelyn Biosciences is a pioneering gene therapy CDMO spun out of Nationwide Children’s Hospital in Columbus, Ohio, in 2020. The company provides gene therapy products to its clients worldwide to support the development of therapies for rare and prevalent diseases. They have decades of expertise in viral vector manufacturing of research-grade AAV vectors for academic institutions and biopharmaceutical clients for use in preclinical and clinical research studies. The company also offers plasmid manufacturing services from the initial trial stage to the clinical stage. Andelyn Biosciences currently assists their clients from the preclinical phase into phase III.
